SHARON BIO-MEDICINE LTD.
Market Cap.(`)
|
1.90 Cr.
|
P/BV
|
0.00
|
Book Value (`)
|
-1,025.68
|
52 Week High/Low ( ` )
|
7/3
|
FV/ML
|
2/1
|
P/E(X)
|
0.10
|
Book Closure
|
27/09/2016
|
EPS (`)
|
33.02
|
Div Yield (%)
|
0.00
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
Months | 9 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 253.45 | 838.46 | 1324.79 | 1073.52 | 804.14 |
Total Operating Revenues | 253.45 | 838.46 | 1324.79 | 1073.52 | 804.14 |
| | | | | |
Other Income | 1.95 | 2.63 | 1.93 | 1.19 | 1.24 |
Total Revenue | 255.40 | 841.10 | 1326.73 | 1074.71 | 805.38 |
| | | | | |
EXPENSES | | | | | |
Purchase Of Stock-In Trade | 210.82 | 791.95 | 1185.17 | 979.09 | 714.58 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 121.43 | 21.03 | -62.21 | -64.02 | -41.00 |
Employee Benefit Expenses | 16.55 | 19.86 | 19.16 | 14.71 | 14.50 |
Finance Costs | 70.98 | 93.65 | 58.63 | 43.06 | 34.26 |
Depreciation And Amortisation Expenses | 15.01 | 19.26 | 15.35 | 12.13 | 8.86 |
Other Expenses | 38.50 | 39.97 | 25.17 | 22.71 | 19.94 |
Total Expenses | 473.30 | 985.71 | 1241.27 | 1007.67 | 751.14 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -217.89 | -144.61 | 85.46 | 67.04 | 54.24 |
| | | | | |
Exceptional Items | -72.41 | -84.63 | 0.00 | 0.00 | -0.03 |
Profit/Loss Before Tax | -290.30 | -229.24 | 85.46 | 67.04 | 54.21 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 0.00 | 0.00 | 13.01 | 12.00 | 9.10 |
Deferred Tax | 8.48 | 1.52 | 2.13 | 1.33 | 2.34 |
Tax For Earlier Years | 1.49 | 3.15 | 0.00 | 0.00 | 0.00 |
Total Tax Expenses | 9.97 | 4.66 | 15.14 | 13.33 | 11.44 |
Profit/Loss After Tax And Before ExtraOrdinary Items | -300.27 | -233.90 | 70.32 | 53.71 | 42.77 |
| | | | | |
Profit/Loss From Continuing Operations | -300.27 | -233.90 | 70.32 | 53.71 | 42.77 |
| | | | | |
Profit/Loss For The Period | -300.27 | -233.90 | 70.32 | 53.71 | 42.77 |
Consolidated Profit/Loss After MI And Associates | -300.27 | -233.90 | 70.32 | 53.71 | 42.77 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | -25.25 | -17.53 | 5.27 | 50.87 | 40.52 |
Diluted EPS (Rs.) | -19.44 | -12.37 | 3.72 | 49.20 | 39.19 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 0.00 | 3.80 | 1.58 | 0.00 |
Tax On Dividend | 0.00 | 0.00 | 0.65 | 0.27 | 0.00 |